Accorto is heading to Boston for RESI, September 22 and 23 at the Westin Copley Place, part of Biotech Week Boston.
RESI is where early-stage medtech, diagnostics, and digital health companies meet the investors funding them. The regulatory pathway question surfaces in nearly every one of those conversations, and it is considerably cheaper to answer before a term sheet depends on it.
Anders Horn will be on site both days of RESI and in Boston for the wider Biotech Week. If you are in town for any part of the week and your FDA pathway is still an open question, he is glad to find time.
